Copyright
©The Author(s) 2004.
World J Gastroenterol. May 15, 2004; 10(10): 1466-1470
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1466
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1466
Group | n | Positive rate of annexin I expression (%) | P value |
Normal pancreas | 38 | 18.4 (7/38) | < 0.0001 |
Pancreatic cancer | 42 | 71.4 (30/42) | |
Ductal adenocarcinoma | 32 | 75 (24/32) | |
Mucinous adenocarcinoma | 6 | 83.3 (5/6) | |
Acinar cell carcinoma | 4 | 25 (1/4) | |
Islet cell carcinoma | 7 | 57.1 (4/7) | |
Ampulla of Vater carcinoma | 7 | 57.1 (4/7) |
Clinicopathologic factors | n | Positive expression rate of annexin I (%) | P value |
Histological differentiation | 0.012 | ||
High and moderate | 21 | 71.4 (15/21) | |
Poor | 11 | 81.8 (9/11) | |
Lymph node metastasis | 0.810 | ||
Yes | 8 | 75 (6/8) | |
No | 34 | 73.5 (25/3) | |
TNM stage | 0.551 | ||
I | 15 | 66.7 (10/15) | |
II | 21 | 81 (17/21) | |
III | 5 | 60 (3/5) |
- Citation: Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B, Zhou LP, Liu F, Zhang JS, Wang K, Xie YQ, Shao YF, Zhao XH. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10(10): 1466-1470
- URL: https://www.wjgnet.com/1007-9327/full/v10/i10/1466.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i10.1466